Application of Cymbopogon plant extractive as insulin sensitizing medicine

A technology of insulin sensitization, citronella, applied in the field of use of citronella plant extracts as insulin sensitization drugs, can solve the problem of no compound etc.

Active Publication Date: 2014-06-11
INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has been reported that leaves and roots contain insulin-like substances, which are off-white, odorless and slightly bitter powder, not alkaloids or glycosides, nor tannins; its insulin potency is: oral administration of 1g is equivalent to 440 units, and subcutaneous injection is equivalent to 880 units. unit [Liu Yongmin, Shawuti. Yin Kemu, Uyghur Pharmaceutical Journal (Volume 1), Xinjiang People's Publishing House, Urumqi, Xinjiang, 1986: 320], but there is no report on the structure of this compound so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Cymbopogon plant extractive as insulin sensitizing medicine
  • Application of Cymbopogon plant extractive as insulin sensitizing medicine
  • Application of Cymbopogon plant extractive as insulin sensitizing medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Example 1. Aqueous Extract of Citronella (Cymbopogon Citratus)

[0061] Citronella (Cymbopogon Citratus) aerial part 500g, heat reflux with 5000ml distilled water, extract three times (5000ml / time), extract 1-1.5 hours each time, extract 140.0g water extract after decompression concentration, dissolve in 500ml Add ethanol to water until the alcohol content reaches 70% (volume ratio), precipitate, filter, and concentrate the filtrate to dryness to obtain 85.0 g of a yellow powdery solid (CC-S).

Embodiment 2

[0062] Example 2. Rue (Cymbopogon distans (Nees) Wats.) water extract

[0063] Rue grass (Cymbopogon distans (Nees) Wats.) whole plant 1000g, heat reflux with 5000ml of distilled water, extract three times (5000ml / time), extract 1.5-2.0 hours each time, extract under reduced pressure and concentrate to get water extract 215.0 g, dissolved in 1000ml of water, add ethanol until the alcohol content reaches 70% (volume ratio), precipitate, filter, and concentrate the filtrate to dryness to obtain 155.0g of yellow powdery solid (CD-S).

Embodiment 3

[0064] Example 3. Aqueous extract of Cymbopogon caesius (Nees) Stapf

[0065]Green Lemongrass (Cymbopogon caesius (Nees) Stapf) leaves 500g, heat reflux with 2500ml of distilled water, extract three times (2500ml / time), extract for 1.5-2.0 hours each time, extract under reduced pressure and concentrate to obtain 120.0g of water extract , dissolved in 500ml of water, add ethanol until the alcohol content reaches 70% (volume ratio), precipitate, filter, and concentrate the filtrate to dryness to obtain 60.0g of yellow powdery solid (QCC-S).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an extractive which is extracted from a Cymbopogon plant and is capable of being used as an insulin sensitizing medicine, a preparation method of the extractive, a medicine composition which contains the Cymbopogon plant or the extractive and an application of the Cymbopogon plant or the extractive and the medicine composition thereof as a medicine. The extractive disclosed by the invention can be used as the insulin sensitizing medicine and a health care product especially.

Description

technical field [0001] The present invention relates to an extract extracted from citronella (Cymbopogon) which can be used as an insulin-sensitizing drug, a preparation method of the extract, a pharmaceutical composition containing citronella (Cymbopogon) or the extract of the genus, And the citronella plant (Cymbopogon) or the extract of the genus and the pharmaceutical composition thereof can be used as medicine, especially can be used as insulin-sensitizing medicine and health care product. Background technique [0002] Diabetes mellitus is a group of chronic metabolic disorder syndromes characterized by persistent high blood sugar [Xiang Hongding, Diabetes Epidemiology, Diagnosis and Typing and Principles of Prevention and Treatment, Chinese Medical Information Herald, 2004, 19(5): 18-18.]. Caused by relative or absolute deficiency of insulin and decreased sensitivity of target tissues to insulin (insulin resistance), resulting from a combination of genetic and environ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P5/50
Inventor 吉腾飞叶菲苏亚伦田金英王爱国杨建波张晓琳张孟孟杨晓萌王丽
Owner INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap